Atlas Trials

Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone

Clinical trial NCT02532634 · COMPLETED

Trial details

NCT number
NCT02532634
Sponsor
Kangdong Sacred Heart Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
CancerTumors
Start date
2015-08-19
Primary completion
2018-05-08
Enrollment
292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.